Adaptation of Pseudomonas aeruginosa to the cystic fibrosis airway: an evolutionary perspective

[1]  C. von Buchwald,et al.  Colonisation and infection of the paranasal sinuses in cystic fibrosis patients is accompanied by a reduced PMN response. , 2012, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

[2]  D. Ohman,et al.  Identification of Genes in the σ22 Regulon of Pseudomonas aeruginosa Required for Cell Envelope Homeostasis in Either the Planktonic or the Sessile Mode of Growth , 2012, mBio.

[3]  G. Beslon,et al.  New insights into bacterial adaptation through in vivo and in silico experimental evolution , 2012, Nature Reviews Microbiology.

[4]  Susan Murray,et al.  Decade-long bacterial community dynamics in cystic fibrosis airways , 2012, Proceedings of the National Academy of Sciences.

[5]  C. von Buchwald,et al.  CT of the paranasal sinuses is not a valid indicator for sinus surgery in CF patients. , 2012, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

[6]  H. Goossens,et al.  EPOS 2012: European position paper on rhinosinusitis and nasal polyps 2012. A summary for otorhinolaryngologists , 2012, Rhinology journal.

[7]  Joanna B. Goldberg,et al.  Parallel bacterial evolution within multiple patients identifies candidate pathogenicity genes , 2011, Nature Genetics.

[8]  Forest Rohwer,et al.  Spatial distribution of microbial communities in the cystic fibrosis lung , 2011, The ISME Journal.

[9]  Nathan E Lewis,et al.  Microbial laboratory evolution in the era of genome-scale science , 2011, Molecular systems biology.

[10]  S. Molin,et al.  Microbial ecology and adaptation in cystic fibrosis airways. , 2011, Environmental microbiology.

[11]  S. Molin,et al.  Evolution and diversification of Pseudomonas aeruginosa in the paranasal sinuses of cystic fibrosis children have implications for chronic lung infection , 2011, The ISME Journal.

[12]  M. Brockhurst,et al.  Pseudomonas aeruginosa population diversity and turnover in cystic fibrosis chronic infections. , 2011, American journal of respiratory and critical care medicine.

[13]  J. Klockgether,et al.  152* Microevolution of the major common Pseudomonas aeruginosa clones C and PA14 in cystic fibrosis lungs , 2011, Journal of Cystic Fibrosis.

[14]  Lutz Wiehlmann,et al.  Pseudomonas aeruginosa Genomic Structure and Diversity , 2011, Front. Microbio..

[15]  Anders Folkesson,et al.  Evolutionary dynamics of bacteria in a human host environment , 2011, Proceedings of the National Academy of Sciences.

[16]  Jeffrey E. Barrick,et al.  Second-Order Selection for Evolvability in a Large Escherichia coli Population , 2011, Science.

[17]  M. Davey,et al.  The activity and hydrogen peroxide sensitivity of the peroxiredoxins from the parasitic nematode Haemonchus contortus. , 2011, Molecular and biochemical parasitology.

[18]  C. von Buchwald,et al.  Decreased mucosal oxygen tension in the maxillary sinuses in patients with cystic fibrosis. , 2011, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

[19]  S. McColley,et al.  Clinical Significance of Microbial Infection and Adaptation in Cystic Fibrosis , 2011, Clinical Microbiology Reviews.

[20]  J. Heesemann,et al.  Adaptation of Pseudomonas aeruginosa during persistence in the cystic fibrosis lung. , 2010, International journal of medical microbiology : IJMM.

[21]  B. Tümmler,et al.  Clonal epidemiology of Pseudomonas aeruginosa in cystic fibrosis. , 2010, International journal of medical microbiology : IJMM.

[22]  A. Bush,et al.  Airway remodelling and its relationship to inflammation in cystic fibrosis , 2010, Thorax.

[23]  Edward M. Marcotte,et al.  Parallel Evolution in Pseudomonas aeruginosa over 39,000 Generations In Vivo , 2010, mBio.

[24]  M. Urbanowski,et al.  Activation of the Pseudomonas aeruginosa AlgU Regulon through mucA Mutation Inhibits Cyclic AMP/Vfr Signaling , 2010, Journal of bacteriology.

[25]  Lei Wang,et al.  Divergence Involving Global Regulatory Gene Mutations in an Escherichia coli Population Evolving under Phosphate Limitation , 2010, Genome biology and evolution.

[26]  Kristian Fog Nielsen,et al.  Early adaptive developments of Pseudomonas aeruginosa after the transition from life in the environment to persistent colonization in the airways of human cystic fibrosis hosts. , 2010, Environmental microbiology.

[27]  Eoin L. Brodie,et al.  Relationship between cystic fibrosis respiratory tract bacterial communities and age, genotype, antibiotics and Pseudomonas aeruginosa. , 2010, Environmental microbiology.

[28]  G. Pier,et al.  Alveolar inflammation in cystic fibrosis. , 2010, Journal of Cystic Fibrosis.

[29]  H. Arets,et al.  Upper and lower airway cultures in children with cystic fibrosis: do not neglect the upper airways. , 2010, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

[30]  D. Hassett,et al.  Pseudomonas aeruginosa biofilm infections in cystic fibrosis: insights into pathogenic processes and treatment strategies , 2010, Expert opinion on therapeutic targets.

[31]  Jeffrey E. Barrick,et al.  Genome evolution and adaptation in a long-term experiment with Escherichia coli , 2009, Nature.

[32]  A. Kharazmi,et al.  Polymorphonuclear leucocytes consume oxygen in sputum from chronic Pseudomonas aeruginosa pneumonia in cystic fibrosis , 2009, Thorax.

[33]  M. Schuster,et al.  Instantaneous Within-Patient Diversity of Pseudomonas aeruginosa Quorum-Sensing Populations from Cystic Fibrosis Lung Infections , 2009, Infection and Immunity.

[34]  Nancy D. Hanson,et al.  Antibacterial-Resistant Pseudomonas aeruginosa: Clinical Impact and Complex Regulation of Chromosomally Encoded Resistance Mechanisms , 2009, Clinical Microbiology Reviews.

[35]  J. Gustafson,et al.  Cystic Fibrosis , 2009, Journal of the Iowa Medical Society.

[36]  C. Di Serio,et al.  Pseudomonas aeruginosa microevolution during cystic fibrosis lung infection establishes clones with adapted virulence. , 2009, American journal of respiratory and critical care medicine.

[37]  Axel Imhof,et al.  Dynamics of adaptive microevolution of hypermutable Pseudomonas aeruginosa during chronic pulmonary infection in patients with cystic fibrosis. , 2009, The Journal of infectious diseases.

[38]  N. Høiby,et al.  Pseudomonas aeruginosa biofilms in the respiratory tract of cystic fibrosis patients , 2009, Pediatric pulmonology.

[39]  D. Ohman,et al.  Use of cell wall stress to characterize σ22 (AlgT/U) activation by regulated proteolysis and its regulon in Pseudomonas aeruginosa , 2009, Molecular microbiology.

[40]  J. Mainz,et al.  Concordant genotype of upper and lower airways P aeruginosa and S aureus isolates in cystic fibrosis , 2009, Thorax.

[41]  N. Høiby,et al.  Early aggressive eradication therapy for intermittent Pseudomonas aeruginosa airway colonization in cystic fibrosis patients: 15 years experience. , 2008, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

[42]  J. Robertson,et al.  Nasal and sinus disease in cystic fibrosis. , 2008, Paediatric respiratory reviews.

[43]  C Kleinstreuer,et al.  Targeted drug-aerosol delivery in the human respiratory system. , 2008, Annual review of biomedical engineering.

[44]  P. Hunter.  The great leap forward , 2008, EMBO reports.

[45]  R. Lenski,et al.  Inaugural Article: Historical contingency and the evolution of a key innovation in an experimental population of Escherichia coli , 2008 .

[46]  M. Berger,et al.  Chronic Inflammation in the Cystic Fibrosis Lung: Alterations in Inter- and Intracellular Signaling , 2008, Clinical reviews in allergy & immunology.

[47]  G. O’Toole,et al.  In Vitro Analysis of Tobramycin-Treated Pseudomonas aeruginosa Biofilms on Cystic Fibrosis-Derived Airway Epithelial Cells , 2008, Infection and Immunity.

[48]  S. Molin,et al.  In Situ Growth Rates and Biofilm Development of Pseudomonas aeruginosa Populations in Chronic Lung Infections , 2007, Journal of bacteriology.

[49]  F. Taddei,et al.  Dissecting the Genetic Components of Adaptation of Escherichia coli to the Mouse Gut , 2007, PLoS genetics.

[50]  S. Molin,et al.  Characterization of a Pseudomonas putida Rough Variant Evolved in a Mixed-Species Biofilm with Acinetobacter sp. Strain C6 , 2007, Journal of bacteriology.

[51]  Freya Harrison,et al.  Microbial ecology of the cystic fibrosis lung. , 2007, Microbiology.

[52]  L. Chao,et al.  Understanding the Evolutionary Fate of Finite Populations: The Dynamics of Mutational Effects , 2007, PLoS biology.

[53]  David A. D'Argenio,et al.  Growth phenotypes of Pseudomonas aeruginosa lasR mutants adapted to the airways of cystic fibrosis patients , 2007, Molecular microbiology.

[54]  N. Høiby,et al.  Isolation measures for prevention of infection with respiratory pathogens in cystic fibrosis: a systematic review? , 2007, The Journal of hospital infection.

[55]  Lars Jelsbak,et al.  Molecular Epidemiology and Dynamics of Pseudomonas aeruginosa Populations in Lungs of Cystic Fibrosis Patients , 2007, Infection and Immunity.

[56]  R. Austin,et al.  Bacterial metapopulations in nanofabricated landscapes , 2006, Proceedings of the National Academy of Sciences.

[57]  Steven R. Head,et al.  Defining the Pseudomonas aeruginosa SOS Response and Its Role in the Global Response to the Antibiotic Ciprofloxacin , 2006, Journal of bacteriology.

[58]  A. J. Leech,et al.  Cell wall‐inhibitory antibiotics activate the alginate biosynthesis operon in Pseudomonas aeruginosa: roles of σ22 (AlgT) and the AlgW and Prc proteases , 2006, Molecular microbiology.

[59]  C. Braggion,et al.  Isolation measures for prevention of infection with respiratory pathogens in cystic fibrosis: a systematic review. , 2006, The Journal of hospital infection.

[60]  A. Griffin,et al.  Social evolution theory for microorganisms , 2006, Nature Reviews Microbiology.

[61]  David A. D'Argenio,et al.  Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[62]  Nigel F. Delaney,et al.  Darwinian Evolution Can Follow Only Very Few Mutational Paths to Fitter Proteins , 2006, Science.

[63]  M. Whiteley,et al.  Microarray Analysis of the Osmotic Stress Response in Pseudomonas aeruginosa , 2006, Journal of bacteriology.

[64]  G. Döring,et al.  Eradication of Pseudomonas aeruginosa in cystic fibrosis patients , 2006, European Respiratory Journal.

[65]  Edward A Graviss,et al.  Genome-Wide Analysis of Group A Streptococci Reveals a Mutation That Modulates Global Phenotype and Disease Specificity , 2006, PLoS pathogens.

[66]  J. Carlin,et al.  Lower Airway Inflammation in Infants with Cystic Fibrosis Detected by Newborn Screening , 2005, Pediatric pulmonology.

[67]  N. Høiby,et al.  Eradication of early Pseudomonas aeruginosa infection. , 2005, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

[68]  D. Wozniak,et al.  Understanding the control of Pseudomonas aeruginosa alginate synthesis and the prospects for management of chronic infections in cystic fibrosis , 2005, Molecular microbiology.

[69]  K. Poole.  Aminoglycoside Resistance in Pseudomonas aeruginosa , 2005, Antimicrobial Agents and Chemotherapy.

[70]  Blaise R. Boles,et al.  Self-generated diversity produces "insurance effects" in biofilm communities. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[71]  H. Baker,et al.  MucA-Mediated Coordination of Type III Secretion and Alginate Synthesis in Pseudomonas aeruginosa , 2004, Journal of bacteriology.

[72]  M. Ranke,et al.  Antioxidant deficiency in cystic fibrosis: when is the right time to take action? , 2004, The American journal of clinical nutrition.

[73]  N. Høiby,et al.  Early intervention and prevention of lung disease in cystic fibrosis: a European consensus. , 2004, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

[74]  P. Gøtzsche,et al.  Antibody response to Pseudomonas aeruginosa in cystic fibrosis patients: A marker of therapeutic success?—A 30‐year Cohort study of survival in Danish CF patients after onset of chronic P. aeruginosa lung infection , 2004, Pediatric pulmonology.

[75]  Martin Schuster,et al.  Pseudomonas aeruginosa Biofilms Exposed to Imipenem Exhibit Changes in Global Gene Expression and β-Lactamase and Alginate Production , 2004, Antimicrobial Agents and Chemotherapy.

[76]  J. Emerson,et al.  Significant microbiological effect of inhaled tobramycin in young children with cystic fibrosis. , 2003, American journal of respiratory and critical care medicine.

[77]  M. Denton,et al.  Evaluation of a new definition for chronic Pseudomonas aeruginosa infection in cystic fibrosis patients. , 2003, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

[78]  F. Ratjen,et al.  Cystic fibrosis , 2003, The Lancet.

[79]  U. Römling,et al.  Impact of large chromosomal inversions on the adaptation and evolution of Pseudomonas aeruginosa chronically colonizing cystic fibrosis lungs , 2002, Molecular microbiology.

[80]  Christian Koch,et al.  Early infection and progression of cystic fibrosis lung disease , 2002, Pediatric pulmonology.

[81]  C. Branger,et al.  Identification of PSE and OXA beta-lactamase genes in Pseudomonas aeruginosa using PCR-restriction fragment length polymorphism. , 2002, The Journal of antimicrobial chemotherapy.

[82]  Richard C Boucher,et al.  Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients. , 2002, The Journal of clinical investigation.

[83]  J. Bull,et al.  Profiles of adaptation in two similar viruses. , 2001, Genetics.

[84]  E. Bingen,et al.  Genotypic characterization of Pseudomonas aeruginosa strains recovered from patients with cystic fibrosis after initial and subsequent colonization , 2001, Pediatric pulmonology.

[85]  N. Høiby,et al.  Characterization of paired mucoid/non-mucoid Pseudomonas aeruginosa isolates from Danish cystic fibrosis patients: antibiotic resistance, beta-lactamase activity and RiboPrinting. , 2001, The Journal of antimicrobial chemotherapy.

[86]  V. Hudson.  Rethinking cystic fibrosis pathology: the critical role of abnormal reduced glutathione (GSH) transport caused by CFTR mutation. , 2001, Free radical biology & medicine.

[87]  J. Emerson,et al.  Longitudinal assessment of Pseudomonas aeruginosa in young children with cystic fibrosis. , 2001, The Journal of infectious diseases.

[88]  R. Lenski,et al.  The population genetics of ecological specialization in evolving Escherichia coli populations , 2000, Nature.

[89]  M. Hodson,et al.  Antibiotic therapy against Pseudomonas aeruginosa in cystic fibrosis: a European consensus. , 2000, The European respiratory journal.

[90]  A. Oliver,et al.  High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection. , 2000, Science.

[91]  J. Burns,et al.  Aminoglycoside-resistance mechanisms for cystic fibrosis Pseudomonas aeruginosa isolates are unchanged by long-term, intermittent, inhaled tobramycin treatment. , 2000, The Journal of infectious diseases.

[92]  Michael Travisano,et al.  Adaptive radiation in a heterogeneous environment , 1998, Nature.

[93]  V. Deretic,et al.  Mucoid Pseudomonas aeruginosa in cystic fibrosis: characterization of muc mutations in clinical isolates and analysis of clearance in a mouse model of respiratory infection , 1997, Infection and immunity.

[94]  J. Hull,et al.  Pulmonary oxidative stress response in young children with cystic fibrosis. , 1997, Thorax.

[95]  V. Deretic,et al.  Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia. , 1996, Microbiological reviews.

[96]  M E Campbell,et al.  Random amplified polymorphic DNA typing of Pseudomonas aeruginosa isolates recovered from patients with cystic fibrosis , 1996, Journal of clinical microbiology.

[97]  P. Phelan,et al.  Lower respiratory infection and inflammation in infants with newly diagnosed cystic fibrosis , 1995, BMJ.

[98]  B. Tümmler,et al.  Epidemiology of chronic Pseudomonas aeruginosa infections in cystic fibrosis. , 1994, The Journal of infectious diseases.

[99]  D. Ohman,et al.  Mucoid-to-nonmucoid conversion in alginate-producing Pseudomonas aeruginosa often results from spontaneous mutations in algT, encoding a putative alternate sigma factor, and shows evidence for autoregulation , 1994, Journal of bacteriology.

[100]  D. Martin,et al.  Analysis of promoters controlled by the putative sigma factor AlgU regulating conversion to mucoidy in Pseudomonas aeruginosa: relationship to sigma E and stress response , 1994, Journal of bacteriology.

[101]  S. Fitzsimmons.  The changing epidemiology of cystic fibrosis. , 1994, Current problems in pediatrics.

[102]  D. Martin,et al.  Conversion of Pseudomonas aeruginosa to mucoidy in cystic fibrosis: environmental stress and regulation of bacterial virulence by alternative sigma factors , 1994, Journal of bacteriology.

[103]  C. Chitnis,et al.  Genetic analysis of the alginate biosynthetic gene cluster of Pseudomonas aeruginosa shows evidence of an operonic structure , 1993, Molecular microbiology.

[104]  D A Siegele,et al.  Microbial competition: Escherichia coli mutants that take over stationary phase cultures. , 1993, Science.

[105]  N. Høiby,et al.  Seasonal onset of initial colonisation and chronic infection with Pseudomonas aeruginosa in patients with cystic fibrosis in Denmark. , 1992, Thorax.

[106]  P. Gilligan,et al.  Microbiology of airway disease in patients with cystic fibrosis , 1991, Clinical Microbiology Reviews.

[107]  A. Kharazmi,et al.  Pseudomonas aeruginosa alginate in cystic fibrosis sputum and the inflammatory response , 1990, Infection and immunity.

[108]  D. Cabral,et al.  Mucoid Pseudomonas aeruginosa Resists Nonopsonic Phagocytosis by Human Neutrophils and Macrophages , 1987, Pediatric Research.

[109]  J. Sobel,et al.  Phagocytosis of mucoid and nonmucoid strains of Pseudomonas aeruginosa. , 1984, Clinical immunology and immunopathology.

[110]  T. Meshulam,et al.  Opsonization and phagocytosis of mucoid and non-mucoidPseudomonas aeruginosa strains , 1982, European Journal of Clinical Microbiology.

[111]  Herman Goossens,et al.  European Position Paper on Rhinosinusitis and Nasal Polyps 2012. , 2012, Rhinology. Supplement.

[112]  Samuel I. Miller,et al.  Pseudomonas aeruginosa lasR mutants are associated with cystic fibrosis lung disease progression. , 2009, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

[113]  R. Boucher.  Relationship of airway epithelial ion transport to chronic bronchitis. , 2004, Proceedings of the American Thoracic Society.

[114]  D. Martin,et al.  Mechanism of conversion to mucoidy in Pseudomonas aeruginosa infecting cystic fibrosis patients. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[115]  S. Pedersen,et al.  Lung infection with alginate-producing, mucoid Pseudomonas aeruginosa in cystic fibrosis. , 1992, APMIS. Supplementum.

[116]  R. Cowan,et al.  Respiratory tract colonization with Pseudomonas aeruginosa in cystic fibrosis: Correlations between anti‐Pseudomonas aeruginosa antibody levels and pulmonary function , 1991, Pediatric pulmonology.

[117]  R. Dean,et al.  Scavenging by alginate of free radicals released by macrophages. , 1989, Free radical biology & medicine.

[118]  J W Costerton,et al.  The bacterial glycocalyx in nature and disease. , 1981, Annual review of microbiology.